Compare · NMHI vs TMO
NMHI vs TMO
Side-by-side comparison of Nature's Miracle Holding Inc. (NMHI) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both NMHI and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO carries a market cap of $172.44B.
- Over the past year, NMHI is up 0.0% and TMO is up 16.1% - TMO leads by 16.1 points.
- TMO has been more active in the news (3 items in the past 4 weeks vs 2 for NMHI).
- TMO has more recent analyst coverage (25 ratings vs 0 for NMHI).
- Company
- Nature's Miracle Holding Inc.
- Thermo Fisher Scientific Inc
- Price
- $1.51+34.22%
- $464.67+0.14%
- Market cap
- -
- $172.44B
- 1M return
- +0.00%
- +3.43%
- 1Y return
- +0.00%
- +16.15%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 2
- 3
- Recent ratings
- 0
- 25
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest NMHI
- NATURE'S MIRACLE HOLDING INC. ANNOUNCES STRATEGIC PARTNERSHIP WITH FARADAY FUTURE ("FFAI")TO SUPPORT NORTH AMERICAN ROBOTICS DEPLOYMENT ALONG WITH DELIVERY OF THE INITIAL AEGIS PRO And NAVI ROBOTS
- NATURE'S MIRACLE HOLDING INC. SECURES $566,000 CONVERTIBLE PREFERRED STOCK FINANCING
- Nature's Miracle Holding Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- Nature's Miracle Holding Inc Reports Q1 2026 Net Income of $2.8 Million with Fully Diluted EPS of $0.01 and Strategic Expansion into U.S. Advanced Contract Manufacturing for Drone and AI Data Center
- SEC Form 10-Q filed by Nature's Miracle Holding Inc.
- NATURE'S MIRACLE HOLDING INC. Enters LOI to Acquire Chicago-Based CM Fabrication, LLC for U.S. Drone Manufacturing
- NATURE'S MIRACLE HOLDING INC. ANNOUNCES STRATEGIC MOU WITH DROMNI INTELLIGENCE TO DEVELOP AI-POWERED AUTONOMOUS ROBOTICS SOLUTIONS FOR U.S. AGRICULTURE, ENERGY AND DATA CENTER MARKETS
- SEC Form NT 10-Q filed by Nature's Miracle Holding Inc.
- SEC Form 10-K filed by Nature's Miracle Holding Inc.
- Amendment: SEC Form 10-Q/A filed by Nature's Miracle Holding Inc.
Latest TMO
- Piper Sandler initiated coverage on Thermo Fisher with a new price target
- Thermo Fisher downgraded by HSBC Securities with a new price target
- Wolfe Research resumed coverage on Thermo Fisher with a new price target
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)